What Will Decide Vertex Stock Over The Next Six Months?
For questions about this article or underlying research, email help@trefis.com. Vertex Pharmaceuticals (VRTX) stock returned 33.8% over the past twelve months, against 13.1% for the S&P 500. On its November 2, 2026 call, management said Vertex, which sold only cystic fibrosis medicines in 2019, will soon sell medicines in five disease areas, and several of […]